Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jazz Pharmaceuticals is a global biopharmaceutical company focused on developing and commercializing innovative medicines for serious diseases with high unmet need. Its portfolio includes leading therapies for sleep disorders such as narcolepsy, epilepsy-related seizures, and various cancers including small cell lung cancer and acute myeloid leukemia. The company has demonstrated strong clinical results with products like Xyrem/Xywav for narcolepsy, Epidiolex/Epidyolex for epilepsy syndromes, Zepzelca for metastatic SCLC, Vyxeos for AML, Defitelio for venoocclusive disease post-transplantation, among others.[1][2][6][8]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Utah Jazz.